Henoch-Schonlein purpura and stroke: Antiphosphatidylethanolamine antibody in CSF and serum

Deborah K. Sokol, J. A. McIntyre, R. A. Short, J. Gutt, D. R. Wagenknecht, J. Biller, B. Garg

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

A 15-year-old girl with features of Henoch-Schonlein purpura and brain infarct had a transient IgA antiphosphatidylethanolamine antibody (aPE) in her serum and CSF that disappeared 5 months after presentation. Serum aPE is known to be associated with thrombotic events. The authors found no aPE in the CSF of two control individuals or in the serum of two patients with active Henoch-Schonlein purpura without neurologic involvement. The patient may represent a variant of antiphospholipid antibody syndrome.

Original languageEnglish (US)
Pages (from-to)1379-1381
Number of pages3
JournalNeurology
Volume55
Issue number9
DOIs
StatePublished - Nov 14 2000

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Henoch-Schonlein purpura and stroke: Antiphosphatidylethanolamine antibody in CSF and serum'. Together they form a unique fingerprint.

  • Cite this

    Sokol, D. K., McIntyre, J. A., Short, R. A., Gutt, J., Wagenknecht, D. R., Biller, J., & Garg, B. (2000). Henoch-Schonlein purpura and stroke: Antiphosphatidylethanolamine antibody in CSF and serum. Neurology, 55(9), 1379-1381. https://doi.org/10.1212/WNL.55.9.1379